Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
Top Cited Papers
Open Access
- 28 October 2011
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 378 (9809), 2081-2087
- https://doi.org/10.1016/s0140-6736(11)61049-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Aspirin and Low-Dose Nitric Oxide–Donating Aspirin Increase Life Span in a Lynch Syndrome Mouse ModelCancer Prevention Research, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2010
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instabilityEuropean Journal Of Cancer, 2002
- New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆Gastroenterology, 1999
- Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selectionProceedings of the National Academy of Sciences, 1998
- Hereditary nonpolyposis colorectal cancer and colonic adenomas: Aggressive adenomas?Seminars in Surgical Oncology, 1995
- Aspirin and the Risk of Colorectal Cancer in WomenNew England Journal of Medicine, 1995